Last €1.69 EUR
Change Today -0.054 / -3.10%
Volume 0.0
EZB On Other Exchanges
Symbol
Exchange
New York
Munich
As of 2:08 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew P. Whiteley

Vice President of Business Development and Chief Operating Officer of Enzo Life Sciences Inc, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$289,397
As of Fiscal Year 2012

Background*

Mr. Andrew P. Whiteley has been Vice President of Business Development at Enzo Biochem Inc. since May 2008. Mr. Whiteley serves as Chief Operating Officer of Enzo Life Sciences Inc., a subsidiary of Enzo Biochem Inc. He served as Vice President of Bioinformatics and Vice President, Sequencing Business at Amersham Pharmacia Biotech, Inc., a provider of integrated drug discovery solutions since January 2000. He served as the President of Vitra Bioscience, Inc. He served ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

Former Chief Executive Officer, President and Director
2000-N/A
Former Chairman of the Board, Chief Executive Officer and President

Education*

Bachelor's Degree 1980
Nottingham University

Other Affiliations*

Annual Compensation*

Salary$220,000
Total Annual Compensation$220,000

Stock Options*

Restricted Stock Awards$12,300
All Other Compensation$17,097

Total Compensation*

Total Annual Cash Compensation$277,097
Total Short Term Compensation$220,000
Other Long Term Compensation$29,397
Total Calculated Compensation$289,397
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €1.69 EUR -0.054

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffery A. Surges Chief Executive Officer, Director and Chief Executive Officer of Merge Health Care
Merge Healthcare Incorporated
$450.0K
Scipio Carnecchia Chief Executive Officer, President and Director
Accelrys Inc.
$429.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$445.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$613.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$557.9K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.